Cargando…

Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function

AIMS: To examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its precursors with risk of cardiovascular events in acute coronary syndrome (ACS), and determine whether these associations were mediated by renal function. METHODS: In this prospective cohort study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Gimenez, Raul, Peiró, Óscar M., Bonet, Gil, Carrasquer, Anna, Fragkiadakis, Georgios A., Bulló, Mònica, Papandreou, Christopher, Bardaji, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532606/
https://www.ncbi.nlm.nih.gov/pubmed/36211587
http://dx.doi.org/10.3389/fcvm.2022.1000815
_version_ 1784802150500532224
author Sanchez-Gimenez, Raul
Peiró, Óscar M.
Bonet, Gil
Carrasquer, Anna
Fragkiadakis, Georgios A.
Bulló, Mònica
Papandreou, Christopher
Bardaji, Alfredo
author_facet Sanchez-Gimenez, Raul
Peiró, Óscar M.
Bonet, Gil
Carrasquer, Anna
Fragkiadakis, Georgios A.
Bulló, Mònica
Papandreou, Christopher
Bardaji, Alfredo
author_sort Sanchez-Gimenez, Raul
collection PubMed
description AIMS: To examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its precursors with risk of cardiovascular events in acute coronary syndrome (ACS), and determine whether these associations were mediated by renal function. METHODS: In this prospective cohort study, we included 309 patients with ACS. During a mean follow-up of 6.7 years, 131 patients developed major adverse cardiovascular events (MACE) (myocardial infarction, hospitalization for heart failure, and all-cause mortality). Plasma concentrations of TMAO, trimethylamine (TMA), choline, betaine, dimethylglycine and L-carnitine were profiled by liquid chromatography tandem mass spectrometry. Hazard ratios were estimated with multivariable Cox regression models. The mediating role of estimated glomerular filtration rate (eGFR) was tested under a counterfactual framework. RESULTS: After adjustment for traditional cardiovascular risk factors and medications, participants in the highest tertile vs. the lowest tertile of baseline TMAO and dimethylglycine concentrations had a higher risk of MACE [(HR: 1.83; 95% CI: 1.08, 3.09) and (HR: 2.26; 95% CI: 1.17, 3.99), respectively]. However, with regards to TMAO these associations were no longer significant, whereas for dimethylglycine, the associations were attenuated after additional adjustment for eGFR. eGFR mediated the associations of TMAO (58%) and dimethylglycine (32%) with MACE incidence. The associations between dimethylglycine and incident MACE were confirmed in an internal validation. No significant associations were found for TMA, choline, betaine and L-carnitine. CONCLUSION: These findings suggest that renal function may be a key mediator in the association of plasma TMAO with the development of cardiovascular events after ACS. The present findings also support a role of dimethylglycine in the pathogenesis of MACE, which may be mediated, at least partially, by renal function.
format Online
Article
Text
id pubmed-9532606
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95326062022-10-06 Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function Sanchez-Gimenez, Raul Peiró, Óscar M. Bonet, Gil Carrasquer, Anna Fragkiadakis, Georgios A. Bulló, Mònica Papandreou, Christopher Bardaji, Alfredo Front Cardiovasc Med Cardiovascular Medicine AIMS: To examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its precursors with risk of cardiovascular events in acute coronary syndrome (ACS), and determine whether these associations were mediated by renal function. METHODS: In this prospective cohort study, we included 309 patients with ACS. During a mean follow-up of 6.7 years, 131 patients developed major adverse cardiovascular events (MACE) (myocardial infarction, hospitalization for heart failure, and all-cause mortality). Plasma concentrations of TMAO, trimethylamine (TMA), choline, betaine, dimethylglycine and L-carnitine were profiled by liquid chromatography tandem mass spectrometry. Hazard ratios were estimated with multivariable Cox regression models. The mediating role of estimated glomerular filtration rate (eGFR) was tested under a counterfactual framework. RESULTS: After adjustment for traditional cardiovascular risk factors and medications, participants in the highest tertile vs. the lowest tertile of baseline TMAO and dimethylglycine concentrations had a higher risk of MACE [(HR: 1.83; 95% CI: 1.08, 3.09) and (HR: 2.26; 95% CI: 1.17, 3.99), respectively]. However, with regards to TMAO these associations were no longer significant, whereas for dimethylglycine, the associations were attenuated after additional adjustment for eGFR. eGFR mediated the associations of TMAO (58%) and dimethylglycine (32%) with MACE incidence. The associations between dimethylglycine and incident MACE were confirmed in an internal validation. No significant associations were found for TMA, choline, betaine and L-carnitine. CONCLUSION: These findings suggest that renal function may be a key mediator in the association of plasma TMAO with the development of cardiovascular events after ACS. The present findings also support a role of dimethylglycine in the pathogenesis of MACE, which may be mediated, at least partially, by renal function. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9532606/ /pubmed/36211587 http://dx.doi.org/10.3389/fcvm.2022.1000815 Text en Copyright © 2022 Sanchez-Gimenez, Peiró, Bonet, Carrasquer, Fragkiadakis, Bulló, Papandreou and Bardaji. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Sanchez-Gimenez, Raul
Peiró, Óscar M.
Bonet, Gil
Carrasquer, Anna
Fragkiadakis, Georgios A.
Bulló, Mònica
Papandreou, Christopher
Bardaji, Alfredo
Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title_full Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title_fullStr Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title_full_unstemmed Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title_short Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function
title_sort plasma trimethylamine-n-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: mediating effects of renal function
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532606/
https://www.ncbi.nlm.nih.gov/pubmed/36211587
http://dx.doi.org/10.3389/fcvm.2022.1000815
work_keys_str_mv AT sanchezgimenezraul plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT peirooscarm plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT bonetgil plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT carrasqueranna plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT fragkiadakisgeorgiosa plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT bullomonica plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT papandreouchristopher plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction
AT bardajialfredo plasmatrimethylaminenoxideitsprecursorsandriskofcardiovasculareventsinpatientswithacutecoronarysyndromemediatingeffectsofrenalfunction